All Insights
Buyer GuideSweden

MPA Sweden Drug Registration: Sourcing Indian Pharmaceuticals for Nordic Importers

15 November 2026By Tuli Enterprise Export Team

A practical guide for importers and distributors supplying Indian generic medicines to Sweden and the Nordics: MPA rules, documents, labelling and sourcing.

Why Sweden and the Nordics Matter for Indian Generics

Sweden is a mature, quality-focused generic medicines market. Regional healthcare authorities buy through structured tenders, pharmacies routinely substitute generics, and buyers expect complete and consistent documentation. For importers and distributors, the opportunity is real, but market entry is closer to a regulated EU process than to a simple trade shipment.

This guide explains how Indian-made generics reach Sweden and the wider Nordic region, what the Swedish Medical Products Agency (Läkemedelsverket, or MPA) expects, and how to prepare a supply chain that holds up under scrutiny. For wider market comparisons, see our country-by-country export pages.

Understanding the Regulatory Framework

Sweden is an EU member state, so medicines are governed by EU pharmaceutical legislation applied nationally by the MPA. A product cannot simply be imported and sold. It needs a valid marketing authorisation, and the parties handling it need the proper authorisations.

In practice, there are four routes to a marketing authorisation:

  • National procedure: an application made directly to the MPA for the Swedish market only.
  • Mutual recognition procedure: an authorisation already granted in one EU/EEA country is recognised in others.
  • Decentralised procedure: a simultaneous application across several chosen EU/EEA countries, often used for Nordic launches.
  • Centralised procedure: an EMA route, used for specific product categories, resulting in an EU-wide authorisation.

Most Indian generic dossiers are submitted through the decentralised or mutual recognition routes. These are normally filed by a marketing authorisation holder (MAH) established in the EU/EEA. A merchant exporter is therefore typically a supply partner to an MAH, a licensed wholesaler or a tendering distributor, and not the authorisation holder itself.

Who Needs What: Roles in the Supply Chain

Before requesting quotations, clarify where you sit in the chain:

  • Marketing authorisation holder: holds the product authorisation and is responsible for pharmacovigilance and product information.
  • Importer of record: needs an appropriate import authorisation for medicines coming from outside the EU/EEA, plus a Qualified Person (QP) who certifies batch release in the EU/EEA.
  • Wholesale distributor: needs a wholesale distribution authorisation and must operate to Good Distribution Practice.
  • Manufacturing site: must be inspected and found compliant with EU GMP standards by an EEA authority, or otherwise accepted under the applicable EU requirements.

Requirements change, so always confirm current obligations directly with the MPA or a qualified regulatory consultant before committing to a product.

Documents Swedish Buyers Typically Ask For

A complete supplier package shortens evaluation time. Tuli Enterprise works with manufacturing partners to provide the supporting documents below, subject to product and partner:

  1. CTD dossier (Modules 1-5) in a format suitable for EU submission, including quality, non-clinical and clinical or bioequivalence sections.
  2. Certificate of Analysis (CoA) for each batch, with specifications aligned to the relevant pharmacopoeia.
  3. Certificate of Pharmaceutical Product (COPP) issued by the Indian authority.
  4. Free Sale Certificate confirming the product is legally marketed in India.
  5. Stability data in line with ICH guidance for the climatic zone and intended shelf life.
  6. Manufacturing site information and evidence that our manufacturing partners hold relevant GMP-certified quality systems.
  7. Active substance documentation such as a master file reference or equivalent details.

Our guide to pharmaceutical import documentation in the Insights section explains each document in more depth.

Labelling, Language and Packaging

Labelling is where many otherwise sound proposals stall. Swedish-market packs generally require:

  • Outer packaging and patient leaflet in Swedish, as the authorisation requires.
  • Product information consistent with the approved summary of product characteristics.
  • EU-compliant safety features, meaning a unique identifier and anti-tampering device for in-scope prescription products.
  • Batch number and expiry date in the expected format, plus Braille on the outer packaging name where required.

Some Nordic markets use shared or multi-country packs, while others require country-specific artwork. Agree on artwork, pack sizes and any overprinting or secondary packaging activities with your regulatory team early, because late changes cost time. Where final packaging occurs in the EU/EEA, the packaging site needs the appropriate authorisation.

Tenders, Substitution and Price Pressure

Swedish healthcare is organised by regions, and hospital medicines are generally purchased through regional or joint tenders. In the outpatient sector, pharmacies substitute generics according to national substitution rules, and the Dental and Pharmaceutical Benefits Agency (TLV) plays a major role in pricing and reimbursement. Competition is intense, so reliable supply can matter as much as price.

Practical points for tender-focused buyers:

  • Plan buffer stock, since failure to deliver awarded volumes can carry consequences.
  • Ask your supplier for realistic batch capacity and a transparent lead-time breakdown that covers manufacturing, QC release, shipping and EU batch release.
  • Prefer products with multiple approved sources of active substance, to reduce disruption risk.

MOQ, Lead Time and Commercial Terms

MOQ depends on the dosage form, pack size and whether the product is made from existing stock or in a new campaign. Standard formulations sold in commonly packed formats usually have lower minimums than products needing custom Swedish-market packaging. Lead times vary by product and compliance workload. We recommend asking for a written estimate that separates production, documentation and logistics stages, and not relying on a single headline figure.

Shipping is typically by air for urgent or temperature-sensitive consignments, and by sea for larger volumes, with transit through EU hubs. Incoterms, insurance and cold chain handling should be agreed in writing before the purchase order is placed.

Choosing the Right Products to Start With

New entrants usually begin with established molecules in competitive categories, such as anti-infectives, cardiovascular, diabetes and gastrointestinal products, where multi-source supply is accepted. Browse our product catalogue or explore categories on the therapies page to shortlist candidates, then compare them against the existing Swedish authorisations and current market competition.

Private Label and Contract Manufacturing

If you hold, or plan to obtain, a marketing authorisation, you may want products manufactured to your own specifications and artwork. Our contract manufacturing service connects you with qualified partners for third-party production, with documentation support throughout. This route suits MAHs who need dependable supply under their own authorisation.

A Practical Step-by-Step Approach

  1. Define your role: MAH, importer, wholesaler or tender bidder.
  2. Shortlist molecules and check existing Swedish and Nordic market presence.
  3. Request the supplier document package, including CTD, CoA, stability data and site details.
  4. Confirm site GMP status and the QP and batch release arrangements.
  5. Agree on Swedish-language artwork and pack specifications.
  6. Confirm all current requirements with the MPA before submission or commercial launch.
  7. Place a trial order, validate quality, and then scale up volumes.

Request a Quote for the Swedish Market

If you are evaluating Indian generics for Sweden or the wider Nordic region, our export team can share product lists, document availability and indicative terms. Send your requirements through our contact page, message us on WhatsApp at wa.me/919654308142, or email [email protected] with the product name, strength, pack size and target quantity.

Need a supplier for this market?

Tuli Enterprise supplies WHO-GMP certified generics and nutraceuticals worldwide with full registration and export documentation.

Request a Quote